Trevi Therapeutics Inc. (TRVI)
NASDAQ: TRVI
· Real-Time Price · USD
6.18
-0.01 (-0.16%)
At close: May 15, 2025, 3:59 PM
6.34
2.59%
After-hours: May 15, 2025, 07:58 PM EDT
-0.16% (1D)
| Bid | 6.34 |
| Market Cap | 628.78M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.35M |
| EPS (ttm) | -0.45 |
| PE Ratio (ttm) | -13.73 |
| Forward PE | -10.25 |
| Analyst | Buy |
| Ask | 6.47 |
| Volume | 1,091,305 |
| Avg. Volume (20D) | 2,402,191 |
| Open | 6.21 |
| Previous Close | 6.19 |
| Day's Range | 6.12 - 6.33 |
| 52-Week Range | 2.30 - 7.39 |
| Beta | 0.62 |
About TRVI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRVI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TRVI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+41.16%
Trevi Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
5 months ago
+15.83%
Trevi Therapeutics shares are trading higher after HC Wainwright & Co. reiterated a Buy rating on the stock and raised its price target from $6 to $7.5.
